Data / Drug companies / Curium US LLC
Curium US LLC: 35 products in the FDA NDC directory, labeler code 69945
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Curium US LLC (labeler code 69945) lists 35 products in the FDA National Drug Code Directory, covering 15 finished drugs by generic name. By type: 30 prescription drugs, 3 bulk ingredients. Its main marketing category is new drug applications (NDA). The newest product started marketing on October 30, 2026.
The request: Watch Curium US LLC (FDA labeler code 69945): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 69945
- Products in commercial distribution
- 35
- Packages
- 46
- Finished drugs by generic name
- 15
- Prescription products
- 30
- Over the counter products
- 0
- Flagged as original packager
- 29 of 29 products that carry the flag
- Started marketing in the last 12 months
- 2
- Earliest marketing start
- June 15, 1990
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| New drug applications (NDA) | 24 | 68.6% |
| Generic drugs (ANDA) | 5 | 14.3% |
| Bulk ingredients | 3 | 8.6% |
| Drugs for further processing | 2 | 5.7% |
| Biologics (BLA) | 1 | 2.9% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 30 | 85.7% |
| Bulk ingredients | 3 | 8.6% |
| Drugs for further processing | 2 | 5.7% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Technetium tc-99m | 13 | 1 |
| Xenon | 2 | 1 |
| Sodium iodide i 123 | 2 | 2 |
| Indium in -111 pentetreotide | 1 | 1 |
| Technetium tc 99m oxidronate | 1 | 1 |
| Lutetium lu 177 dotatate | 1 | 2 |
| Technetium tc 99m sestamibi | 1 | 2 |
| Thallous chloride, tl 201 | 1 | 1 |
| Kit for the preparation of technetium tc 99m pentetate | 1 | 2 |
| Technetium tc 99m pyrophosphate | 1 | 1 |
| Ioflupane i-123 | 1 | 2 |
| Gallium citrate ga-67 | 1 | 1 |
| Kit for the preparation of technetium tc 99m red blood cells | 1 | 1 |
| Copper cu 64 dotatate | 1 | 1 |
| Technescan tc 99m mertiatide | 1 | 1 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, solution | 17 | 48.6% |
| Injection, powder, lyophilized, for solution | 4 | 11.4% |
| Solution | 2 | 5.7% |
| Kit | 2 | 5.7% |
| Gas | 2 | 5.7% |
| Injection | 2 | 5.7% |
| Powder | 2 | 5.7% |
| Capsule, gelatin coated | 2 | 5.7% |
| Injection, powder, lyophilized, for suspension | 1 | 2.9% |
| Liquid | 1 | 2.9% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Lutetium (lu 177) chloride | 69945-977 | Solution | Drugs for further processing | October 30, 2026 |
| Bexlutry | 69945-177 | Injection | New drug applications (NDA) | September 14, 2026 |
| Kit for the Preparation of Technetium Tc 99m Pentetate | 69945-314 | Injection, powder, lyophilized, for solution | Generic drugs (ANDA) | April 8, 2025 |
| Ioflupane I 123 | 69945-166 | Injection, solution | Generic drugs (ANDA) | March 31, 2022 |
| Germanium-68 | 69945-544 | Liquid | Drugs for further processing | October 22, 2020 |
| Detectnet | 69945-064 | Injection, solution | New drug applications (NDA) | September 14, 2020 |
| Pulmotech MAA | 69945-139 | Injection, powder, lyophilized, for suspension | Biologics (BLA) | March 20, 2020 |
| Strontium sr-82 chloride | 69945-082 | Solution | Bulk ingredients | July 10, 2018 |
| Xenon, Xe-133 | 69945-098 | Gas | New drug applications (NDA) | March 30, 2016 |
| Xenon, Xe-133 | 69945-097 | Gas | New drug applications (NDA) | March 30, 2016 |
| Oxidronate sodium | 69945-410 | Powder | Bulk ingredients | January 20, 2016 |
| Diethylenetriaminepentaacetic acid | 69945-273 | Powder | Bulk ingredients | January 20, 2016 |
| Sodium iodide i 123 | 69945-601 | Capsule, gelatin coated | Generic drugs (ANDA) | November 4, 2015 |
| THALLOUS CHLORIDE Tl 201 | 69945-120 | Injection, solution | New drug applications (NDA) | November 4, 2015 |
| Technescan PYP | 69945-094 | Injection, powder, lyophilized, for solution | New drug applications (NDA) | October 14, 2015 |
| Octreoscan | 69945-050 | Kit | New drug applications (NDA) | October 14, 2015 |
| Technescan HDP | 69945-091 | Injection, powder, lyophilized, for solution | New drug applications (NDA) | October 13, 2015 |
| Ultra-Technekow V4 | 69945-190 | Injection, solution | New drug applications (NDA) | June 10, 2014 |
| Ultra-Technekow V4 | 69945-160 | Injection, solution | New drug applications (NDA) | June 10, 2014 |
| Ultra-Technekow V4 | 69945-140 | Injection, solution | New drug applications (NDA) | June 10, 2014 |
| Ultra-Technekow V4 | 69945-110 | Injection, solution | New drug applications (NDA) | June 10, 2014 |
| Ultra-Technekow V4 | 69945-075 | Injection, solution | New drug applications (NDA) | June 10, 2014 |
| Ultra-Technekow V4 | 69945-060 | Injection, solution | New drug applications (NDA) | June 10, 2014 |
| Ultra-Technekow V4 | 69945-051 | Injection, solution | New drug applications (NDA) | June 10, 2014 |
| Ultra-Technekow V4 | 69945-035 | Injection, solution | New drug applications (NDA) | June 10, 2014 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.